Alopurinol Belupo 100 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alopurinol belupo 100 mg tablete

belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica, hrvatska - alopurinol - tableta - 100 mg - urbroj: jedna tableta sadrži 100 mg alopurinola

Alopurinol Belupo 200 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alopurinol belupo 200 mg tablete

belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica, hrvatska - alopurinol - tableta - 200 mg - urbroj: jedna tableta sadrži 200 mg alopurinola

Alopurinol PharmaS 100 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alopurinol pharmas 100 mg tablete

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - alopurinol - tableta - 100 mg - urbroj: jedna tableta sadrži 100 mg alopurinola

Alopurinol Sandoz 100 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alopurinol sandoz 100 mg tablete

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - alopurinol - tableta - 100 mg - urbroj: jedna tableta sadrži 100 mg alopurinola

Humira Europska Unija - hrvatski - EMA (European Medicines Agency)

humira

abbvie deutschland gmbh co. kg - adalimumab - spondylitis, ankylosing; arthritis, juvenile rheumatoid; uveitis; colitis, ulcerative; psoriasis; arthritis, psoriatic; crohn disease; arthritis, rheumatoid - imunosupresivi - molimo pogledajte dokument s informacijama o proizvodu.

Skyrizi Europska Unija - hrvatski - EMA (European Medicines Agency)

skyrizi

abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - imunosupresivi - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.

Xaluprine (previously Mercaptopurine Nova Laboratories) Europska Unija - hrvatski - EMA (European Medicines Agency)

xaluprine (previously mercaptopurine nova laboratories)

nova laboratories ireland limited - 6-merkaptopurin monohidrat - leukemija, limfoid - antineoplastična sredstva - xaluprin je indiciran za liječenje akutne limfoblastične leukemije (all) u odraslih, adolescenata i djece.